<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753441</url>
  </required_header>
  <id_info>
    <org_study_id>NNR-02</org_study_id>
    <nct_id>NCT00753441</nct_id>
  </id_info>
  <brief_title>Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head</brief_title>
  <acronym>STENTBY</acronym>
  <official_title>Endoscopic Biliary Stenting on Demand Versus Surgical Biliary Bypass for Palliation of Patients With Advanced Cancer of the Pancreatic Head: STENTBY - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prognosis of patients with unresectable pancreatic cancer is dismal. Hence, palliation of&#xD;
      tumor-associated symptoms, in particular jaundice due to low bile duct obstruction and&#xD;
      gastric outlet obstruction, is the primary aim of these patients' care. Endoscopic stenting&#xD;
      and surgical bypass are currently the two competing treatment options. There is currently no&#xD;
      randomized trial comparing the recently developed metal stents to surgical bypass.&#xD;
      Furthermore, there is very limited data on quality of life of these patients receiving either&#xD;
      therapy. While endoscopic stenting represents the less invasive treatment, surgery may&#xD;
      provide better long-term control requiring one-time treatment. Due to the incomplete evidence&#xD;
      the present randomized controlled trial is designed to compare quality of life of patients&#xD;
      undergoing endoscopic stenting on demand or surgical bypass for palliation of symptoms caused&#xD;
      by cancer of the pancreatic head requiring with low bile duct obstruction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low patient accrual&#xD;
  </why_stopped>
  <start_date type="Actual">February 1, 2009</start_date>
  <completion_date type="Actual">August 16, 2017</completion_date>
  <primary_completion_date type="Actual">August 16, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum bilirubin</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure-related complications</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical bypass (choledochojejunostomy, in combination with gastroenterostomy if necessary)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic biliary stenting using metal stent (completed by duodenal stent, if necessary)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical bypass</intervention_name>
    <description>Surgical bypass (choledochojejunostomy, in combination with gastroenterostomy if necessary)</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic stenting</intervention_name>
    <description>Placement of a biliary metal stent (in combination with a duodenal metal stent in case of gastric outlet obstruction if necessary)</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age equal or greater than 18 years&#xD;
&#xD;
          -  Diagnosis of unresectable cancer of the pancreatic head (after clinical, laboratory,&#xD;
             radiological assessment) requiring palliative treatment for biliary obstruction. In&#xD;
             unclear cases an exploratory laparotomy will be performed and resectability will be&#xD;
             evaluated intraoperatively&#xD;
&#xD;
          -  Operability certified by anesthesiologist&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intervention technically/medically not feasible&#xD;
&#xD;
          -  Expected lack of compliance&#xD;
&#xD;
          -  One treatment option considered to be clearly in favor of the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Schmied, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of General, Visceral and Transplantation Surgery, University of Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universityhospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>September 15, 2008</study_first_submitted>
  <study_first_submitted_qc>September 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2008</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Nuh Rahbari</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pancreatic cancer</keyword>
  <keyword>Bile duct obstruction</keyword>
  <keyword>Stent</keyword>
  <keyword>Bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

